BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37830501)

  • 1. Identifying Rare Genetic Determinants for Improved Polygenic Risk Prediction of Bone Mineral Density and Fracture Risk.
    Lu T; Forgetta V; Zhou S; Richards JB; Greenwood CM
    J Bone Miner Res; 2023 Dec; 38(12):1771-1781. PubMed ID: 37830501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a polygenic risk score to improve screening for fracture risk: A genetic risk prediction study.
    Forgetta V; Keller-Baruch J; Forest M; Durand A; Bhatnagar S; Kemp JP; Nethander M; Evans D; Morris JA; Kiel DP; Rivadeneira F; Johansson H; Harvey NC; Mellström D; Karlsson M; Cooper C; Evans DM; Clarke R; Kanis JA; Orwoll E; McCloskey EV; Ohlsson C; Pineau J; Leslie WD; Greenwood CMT; Richards JB
    PLoS Med; 2020 Jul; 17(7):e1003152. PubMed ID: 32614825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Causes of Fracture Beyond Bone Mineral Density: Evidence From Human Genetics.
    Lu T; Forgetta V; Greenwood CMT; Richards JB
    J Bone Miner Res; 2022 Aug; 37(8):1592-1602. PubMed ID: 35689460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved prediction of fracture risk leveraging a genome-wide polygenic risk score.
    Lu T; Forgetta V; Keller-Baruch J; Nethander M; Bennett D; Forest M; Bhatnagar S; Walters RG; Lin K; Chen Z; Li L; Karlsson M; Mellström D; Orwoll E; McCloskey EV; Kanis JA; Leslie WD; Clarke RJ; Ohlsson C; Greenwood CMT; Richards JB
    Genome Med; 2021 Feb; 13(1):16. PubMed ID: 33536041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and rare variants in the exons and regulatory regions of osteoporosis-related genes improve osteoporotic fracture risk prediction.
    Lee SH; Kang MI; Ahn SH; Lim KH; Lee GE; Shin ES; Lee JE; Kim BJ; Cho EH; Kim SW; Kim TH; Kim HJ; Yoon KH; Lee WC; Kim GS; Koh JM; Kim SY
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2400-11. PubMed ID: 25119311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).
    Stürznickel J; Rolvien T; Delsmann A; Butscheidt S; Barvencik F; Mundlos S; Schinke T; Kornak U; Amling M; Oheim R
    J Bone Miner Res; 2021 Feb; 36(2):271-282. PubMed ID: 33118644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of the BMD-related comprehensive genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures.
    Xiao X; Wu Q
    Osteoporos Int; 2023 Apr; 34(4):681-692. PubMed ID: 36622390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilize polygenic risk score to enhance fracture risk estimation and improve the performance of FRAX in patients with osteoporosis.
    Chen JJ; Chen IC; Wei CY; Lin SY; Chen YM
    Arch Osteoporos; 2023 Dec; 18(1):147. PubMed ID: 38036866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic disparities in fracture risk assessment using polygenic scores.
    Xiao X; Wu Q
    Osteoporos Int; 2023 May; 34(5):943-953. PubMed ID: 36840773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study.
    Cerani A; Zhou S; Forgetta V; Morris JA; Trajanoska K; Rivadeneira F; Larsson SC; Michaëlsson K; Richards JB
    BMJ; 2019 Aug; 366():l4410. PubMed ID: 31371314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
    van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
    JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study.
    Trajanoska K; Morris JA; Oei L; Zheng HF; Evans DM; Kiel DP; Ohlsson C; Richards JB; Rivadeneira F;
    BMJ; 2018 Aug; 362():k3225. PubMed ID: 30158200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.
    Costantini A; Mäkitie RE; Hartmann MA; Fratzl-Zelman N; Zillikens MC; Kornak U; Søe K; Mäkitie O
    J Bone Miner Res; 2022 Sep; 37(9):1623-1641. PubMed ID: 35949115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Burden of Common Risk Alleles in Children With a Significant Fracture History.
    Manousaki D; Kämpe A; Forgetta V; Makitie RE; Bardai G; Belisle A; Li R; Andersson S; Makitie O; Rauch F; Richards JB
    J Bone Miner Res; 2020 May; 35(5):875-882. PubMed ID: 31914204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic risk factors identified in populations of European descent do not improve the prediction of osteoporotic fracture and bone mineral density in Chinese populations.
    Li YM; Peng C; Zhang JG; Zhu W; Xu C; Lin Y; Fu XY; Tian Q; Zhang L; Xiang Y; Sheng V; Deng HW
    Sci Rep; 2019 Apr; 9(1):6086. PubMed ID: 30988369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 613 new loci associated with heel bone mineral density and a polygenic risk score for bone mineral density, osteoporosis and fracture.
    Kim SK
    PLoS One; 2018; 13(7):e0200785. PubMed ID: 30048462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Polygenic Risk Score as a Risk Factor for Medication-Associated Fractures.
    Manousaki D; Forgetta V; Keller-Baruch J; Zhao K; Greenwood CM; Mooser V; Bassett JD; Leslie WD; Richards JB
    J Bone Miner Res; 2020 Oct; 35(10):1935-1941. PubMed ID: 32511779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Effect of Sodium-Glucose Cotransporter 2 Inhibition on Fracture Risk: Evidence From Mendelian Randomization and Genetic Association Study.
    Dai H; Zheng L; Zhu Z; Geng X; Hou T; Wang Q; Zhu Y; Lin H; Wang S; Zheng R; Zhao Z; Li M; Lu J; Xu Y; Wang T; Liu J; Ning G; Wang W; Bi Y; Zheng J; Xu M
    J Bone Miner Res; 2023 Nov; 38(11):1645-1653. PubMed ID: 37436694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry.
    Breedon JR; Marshall CR; Giovannoni G; van Heel DA; ; Dobson R; Jacobs BM
    Brain Commun; 2023; 5(2):fcad041. PubMed ID: 37006331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.